GL1X · GenesisL1 explorer

Research workbench

Use of an ion-binding site to bypass the 1000-atom limit to ab initio structure determination by direct methods

Analyse Use of an ion-binding site to bypass the 1000-atom limit to ab initio structure… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1SX7
Type
protein
Length
164 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysozyme
EC
3.2.1.17
UniProt
P00720
Ligands
RB, CL
Pockets
1 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 62% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysozyme (EC 3.2.1.17)protein16462% helix, 8% strandP00720

Ligands and binding sites

  • RB · Rubidium ion · metal · 5 copies · chains A
  • CL · Chloride ion · ion · 4 copies · chains A
  • BME · Beta-mercaptoethanol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12010.500.7626RB

Compared structures

  • 1SX7 · Use of an ion-binding site to bypass the 1000-atom limit to ab initio structure… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.